Home › Products › Oncology › Brcaone 150mg Tablet
Brcaone 150mg Tablet
Salt Composition: OLAPARIB
- Manufacturer: EMCURE PHARMACEUTICALS LTD
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Store Brcaone 150mg Tablet Tablet in the original package at room temperature (20°C to 25°C). Keep it out of reach from children.
₹15000.00₹42187.50
Inclusive of all taxes
Product Introduction
Brcaone 150mg Tablet is a PARP (poly[adenosine diphosphate-ribose] polymerase inhibitor) containing olaparib. It is used to treat pancreatic and prostate cancer. The medication may be administered alone or in combination with other anticancer medications.
Do not take olaparib if you are allergic to the active ingredient or other components of the medicine. Inform your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will order blood tests before commencing treatment and monthly during therapy, as this medicine may reduce red blood cell, white blood cell, and platelet counts.
Inform your healthcare provider before starting treatment if you have been diagnosed with problems affecting your lungs, liver, heart, or kidneys. Do not use this medication during pregnancy, as it may harm the fetus and cause miscarriage. Women of reproductive age should obtain a pregnancy test before beginning this medication. It is recommended to continue using contraception for at least six months after treatment completion.
Do not breastfeed while receiving treatment, as it is unknown whether Brcaone 150mg Tablet passes into breast milk. Men should not donate sperm for at least 3 months after treatment completion. Inform your doctor of all medicines you are taking, including prescription medications, over-the-counter drugs, vitamins, and supplements.
Uses
Treatment of Prostate cancer Metastatic Pancreatic cancer
How it works
Brcaone 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Brcaone 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
How to Use
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Brcaone 150mg Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Brcaone 150mg Tablet tablet at the same time every day.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache Serious Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems
Expert Tips
Brcaone 150mg Tablet can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Brcaone 150mg Tablet should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Brcaone 150mg Tablet. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Brcaone 150mg Tablet can be an effective treatment option for certain types of cancer.
References
- Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
- AstraZeneca UK Limited, European Medicines Compendium (EMC), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
- AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf
Safety Advice
Pregnancy: unsafe It is not recommended to take Brcaone 150mg Tablet during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.
Lungs: Consult your doctor It is unknown whether Brcaone 150mg Tablet is safe in individuals with liver disorders. Inform your physician if you have any liver problems before starting the treatment.
Breastfeeding: unsafe It is unknown whether Brcaone 150mg Tablet Tablet passes into the breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.